Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naoki Nagata

Showing results (61-70 of 85) with videos related to

Pageof 9
Sort By:
Oncology|May 28, 2016
A Phase II Study of Third-Line Combination Chemotherapy with Bevacizumab Plus S-1 for Metastatic Colorectal Cancer with Mutated KRAS (SAVIOR Study)Motoki Yoshida, Akinori Takagane, Yasuhiro Miyake, et al.
Cancer Chemotherapy and Pharmacology|November 13, 2015
Effect of pH adjustment by mixing steroid for venous pain in colorectal cancer patients receiving oxaliplatin through peripheral vein: a multicenter randomized phase II study (APOLLO)Taishi Hata, Michitaka Honda, Michiya Kobayashi, et al.
Oncology Research|October 20, 2004
4-[3,5-Bis(trimethylsilyl)benzamido] benzoic acid inhibits angiogenesis in colon cancer through reduced expression of vascular endothelial growth factorNoritaka Minagawa, Yoshifumi Nakayama, Yuzuru Inoue, et al.
Journal of UOEH|September 12, 2008
[A case of low grade ductal carcinoma in situ of the breast with difficulties in making the preoperative diagnosis after detection by FDG-PET]Yosuke Tsurudome, Takefumi Katsuki, Tetsumi Konishi, et al.
In Vivo (Athens, Greece)|March 31, 2005
4-[3,5-Bis(trimethylsilyl)benzamido] benzoic acid (TAC-101) induces apoptosis in colon cancer partially through the induction of Fas expressionTatsuhiko Sako, Yoshifumi Nakayama, Noritaka Minagawa, et al.
In Vivo (Athens, Greece)|April 18, 2007
4- [3,5-bis(trimethylsilyl)benzamido] benzoic acid (TAC-101) induced fas expression and activated caspase-3 and -8 in a DLD-1 colon cancer cell lineYuzuru Inoue, Yoshifumi Nakayama, Tatsuhiko Sako, et al.
Cancer Chemotherapy and Pharmacology|March 7, 2018
A phase II trial to evaluate the efficacy of panitumumab combined with fluorouracil-based chemotherapy for metastatic colorectal cancer: the PF trialYoshinori Munemoto, Mitsuro Kanda, Koji Oba, et al.
Asian Journal of Endoscopic Surgery|August 21, 2024
First pediatric pelvic surgery with the Senhance® robotic surgical system: A case seriesDaiki Kato, Hiroo Uchida, Chiyoe Shirota, et al.
Hepato-Gastroenterology|December 13, 2005
Phase I study of paclitaxel and cisplatin for patients with advanced or recurrent gastric cancerNaoki Nagata, Michiya Kobayashi, Hiroshi Kojima, et al.
Oncology Letters|October 16, 2019
Association between polymorphisms in EGFR and tumor response during cetuximab and oxaliplatin-based combination therapy in metastatic colorectal cancer: Analysis of data from two clinical trialsHiromichi Maeda, Shoichi Hazama, Shigeyoshi Iwamoto, et al.
Pageof 9

Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
Oncology|May 28, 2016
A Phase II Study of Third-Line Combination Chemotherapy with Bevacizumab Plus S-1 for Metastatic Colorectal Cancer with Mutated KRAS (SAVIOR Study)Motoki Yoshida, Akinori Takagane, Yasuhiro Miyake, et al.
Cancer Chemotherapy and Pharmacology|November 13, 2015
Effect of pH adjustment by mixing steroid for venous pain in colorectal cancer patients receiving oxaliplatin through peripheral vein: a multicenter randomized phase II study (APOLLO)Taishi Hata, Michitaka Honda, Michiya Kobayashi, et al.
Oncology Research|October 20, 2004
4-[3,5-Bis(trimethylsilyl)benzamido] benzoic acid inhibits angiogenesis in colon cancer through reduced expression of vascular endothelial growth factorNoritaka Minagawa, Yoshifumi Nakayama, Yuzuru Inoue, et al.
Journal of UOEH|September 12, 2008
[A case of low grade ductal carcinoma in situ of the breast with difficulties in making the preoperative diagnosis after detection by FDG-PET]Yosuke Tsurudome, Takefumi Katsuki, Tetsumi Konishi, et al.
In Vivo (Athens, Greece)|March 31, 2005
4-[3,5-Bis(trimethylsilyl)benzamido] benzoic acid (TAC-101) induces apoptosis in colon cancer partially through the induction of Fas expressionTatsuhiko Sako, Yoshifumi Nakayama, Noritaka Minagawa, et al.
In Vivo (Athens, Greece)|April 18, 2007
4- [3,5-bis(trimethylsilyl)benzamido] benzoic acid (TAC-101) induced fas expression and activated caspase-3 and -8 in a DLD-1 colon cancer cell lineYuzuru Inoue, Yoshifumi Nakayama, Tatsuhiko Sako, et al.
Cancer Chemotherapy and Pharmacology|March 7, 2018
A phase II trial to evaluate the efficacy of panitumumab combined with fluorouracil-based chemotherapy for metastatic colorectal cancer: the PF trialYoshinori Munemoto, Mitsuro Kanda, Koji Oba, et al.
Asian Journal of Endoscopic Surgery|August 21, 2024
First pediatric pelvic surgery with the Senhance® robotic surgical system: A case seriesDaiki Kato, Hiroo Uchida, Chiyoe Shirota, et al.
Hepato-Gastroenterology|December 13, 2005
Phase I study of paclitaxel and cisplatin for patients with advanced or recurrent gastric cancerNaoki Nagata, Michiya Kobayashi, Hiroshi Kojima, et al.
Oncology Letters|October 16, 2019
Association between polymorphisms in EGFR and tumor response during cetuximab and oxaliplatin-based combination therapy in metastatic colorectal cancer: Analysis of data from two clinical trialsHiromichi Maeda, Shoichi Hazama, Shigeyoshi Iwamoto, et al.
Pageof 9